HSTM Stock News 24.50 05/09/2014 20:35:24 Healthstream Inc (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthstream Inc (HSTM) 24.50 $HSTM

HealthStream Down 15.4% Since SmarTrend Downtrend Call (HSTM)
Comtex SmarTrend(R) - Wed May 07, 9:59AM CDT
SmarTrend identified a Downtrend for HealthStream (NASDAQ:HSTM) on February 24th, 2014 at $28.15. In approximately 2 months, HealthStream has returned 15.42% as of today's recent price of $23.81.

20.6% Return Seen to Date on SmarTrend HealthStream Call (HSTM)
Comtex SmarTrend(R) - Wed Apr 30, 9:18AM CDT
SmarTrend identified a Downtrend for HealthStream (NASDAQ:HSTM) on February 24th, 2014 at $28.15. In approximately 2 months, HealthStream has returned 20.64% as of today's recent price of $22.34.

Healthstream Slumps: HSTM Falls 6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:34AM CDT
Make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 22, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

Why HealthStream (HSTM) Stock Is Down Today
at The Street - Tue Apr 22, 12:35PM CDT
HealthStream (HSTM) shares are down following missed first quarter earnings guidance.

HealthStream Announces First Quarter 2014 Results
Business Wire - Mon Apr 21, 3:30PM CDT
HealthStream, Inc. (NASDAQ: HSTM), a leading provider of workforce development and research / patient experience solutions for the healthcare industry, announced today results for the first quarter ended March 31, 2014.

HealthStream to Broadcast Its First Quarter 2014 Earnings Conference Call Live on the Internet
Business Wire - Thu Apr 17, 8:25AM CDT
HealthStream (NASDAQ: HSTM), a leading provider of workforce development and research / patient experience solutions for the healthcare industry, announced today that it will provide an online Web simulcast of its first quarter 2014 earnings conference call on Tuesday, April 22, 2014. The Company's results for the first quarter ended March 31, 2014 will be released after the close of the market on Monday, April 21, 2014.

HealthStream Has Returned 15.0% Since SmarTrend Recommendation (HSTM)
Comtex SmarTrend(R) - Mon Apr 14, 9:56AM CDT
SmarTrend identified a Downtrend for HealthStream (NASDAQ:HSTM) on February 24th, 2014 at $28.15. In approximately 2 months, HealthStream has returned 15.03% as of today's recent price of $23.92.

Availity Teams up with Precyse and HealthStream - Goal to Ease ICD-10 Training Burden on Providers
Business Wire - Wed Apr 09, 8:01AM CDT
Availity is offering its 350,000 medical provider customers a portable, customizable training program to help physician office staff prepare for massive industrywide changes in medical coding and reimbursement expected next year with ICD-10. By teaming with Precyse University and HealthStream, Availity complements its existing training programs with a comprehensive ICD-10 education solution delivered exclusively through HealthStream's workforce development platform. Availity's physician office/ambulatory facility customers will join the more than 1.2 million learners already using the Precyse University ICD-10 solution powered by HealthStream's workforce development platform, which includes:

Availity Partners with Precyse and HealthStream for Physician Office ICD-10 Education
PR Newswire - Wed Apr 09, 8:00AM CDT
Availity, one of the nation's largest health care information networks, has partnered with Precyse/HealthStream to offer its clients a powerful and unique ICD-10 education program for the physician office/ambulatory market. Precyse and HealthStream have teamed together to offer a unique and comprehensive ICD-10 education solution that is delivered exclusively through HealthStream's workforce development platform. Availity's physician office/ambulatory facility customers will join the more than 1.2 million learners already using the Precyse University ICD-10 solution powered by HealthStream's workforce development platform, which includes:

Downgrade Alert for HealthStream (HSTM)
Comtex SmarTrend(R) - Wed Apr 02, 7:01AM CDT
HealthStream (NASDAQ:HSTM) was downgraded from Outperform to Market Perform at Northland today. The stock closed yesterday at $27.10 on volume of 345,000 shares, above average daily volume of 230,000. HealthStream (NASDAQ:HSTM) has potential upside of 42.5% based on a current price of $27.10 and analysts' consensus price target of $38.62. HealthStream shares should first meet resistance at the 50-day moving average (MA) of $28.95 and find additional resistance at the 200-day MA of $31.85.

Upgrade Alert for HealthStream (HSTM)
Comtex SmarTrend(R) - Wed Apr 02, 7:00AM CDT
HealthStream (NASDAQ:HSTM) was upgraded from Hold to Buy at Noble Financial today. The stock closed yesterday at $27.10 on volume of 345,000 shares, above average daily volume of 230,000. HealthStream, Inc. offers a Web-based solution to the continuing education and training needs of the healthcare community. The Company distributes numerous hours of continuing education and training content to doctors, nurses, allied health professionals, and other healthcare workers through its network of distribution partners.

Precyse University Partners with athenahealth to Provide Comprehensive ICD-10 Education to Physician Practices, Clinics and Ambulatory Settings
PR Newswire - Wed Mar 26, 8:00AM CDT
Precyse University, the most innovative, complete and widely adopted on-site, online and mobile ICD-10 education solution, available exclusively through HealthStream, today announced a partnership with athenahealth, Inc. as part of athenahealth's More Disruption Please (MDP) program. Together, the companies will work to link athenahealth's growing network of more than 50,000 health care providers with the capabilities of Precyse University so they can more efficiently prepare their staffs for the transition to ICD-10 in October 2014. The Precyse/HealthStream solution for ICD-10 education is now used by approximately 1.2 million learners in health care organizations.

ZirMed Partners with Precyse for Physician Office ICD-10 Education
PR Newswire - Thu Mar 13, 8:00AM CDT
ZirMed®, a leading health information connectivity and management solutions company, has partnered with Precyse/HealthStream to offer its clients a powerful and unique ICD-10 education program for the physician office/ambulatory market. Precyse and HealthStream have teamed together to offer a unique and comprehensive ICD-10 education solution that is delivered exclusively through HealthStream's workforce development platform. ZirMed's more than 195,000 providers at over 25,000 locations will be offered access to the following revolutionary benefits and features of the Precyse University Physician Office ICD-10 Education Solution:

HealthStream Acquires Health Care Compliance Strategies; Creates Comprehensive Compliance Solution for Healthcare Providers
Business Wire - Tue Mar 04, 8:25AM CST
HealthStream, Inc. (NASDAQ: HSTM), a leading provider of workforce development and research / patient experience solutions for the healthcare industry, today announced that it has acquired Health Care Compliance Strategies, Inc. (HCCS), a Jericho, New York-based company focused on interactive and engaging online compliance training for healthcare organizations. HealthStream adds to its workforce development solutions with a comprehensive curriculum of premium courseware and an outstanding application for managing conflicts of interest disclosures, along with a team of professionals with extensive industry experience and thought leadership in healthcare compliance.

Precyse / HealthStream's ICD-10 Education Solution Reaches Approximately 1.2 Million Learners
PR Newswire - Wed Feb 26, 8:00AM CST
Precyse University, the most innovative and complete on-site, online and mobile healthcare education solution that is designed to prepare coders, physicians, nurses, case managers, administrative staff and all others impacted by the transition to ICD-10, is gaining increasing dominance in healthcare organizations nationwide. Precyse and HealthStream have teamed together to offer a unique and comprehensive ICD-10 Education Solution that is delivered exclusively through HealthStream's workforce development platform. The Precyse/HealthStream solution for ICD-10 education is now used by approximately 1.2 million learners in healthcare organizations. Precyse was recognized in the recent KLAS report, "ICD-10 Consulting: Roadmap to a Successful Transition," as the only firm in this report to receive 100% positive comments from their clients about their ICD-10 services. Precyse clients praise the Precyse University training program as 'mature, comprehensive, and flexible.' " 1

ACI Worldwide to Present at Upcoming Investor Conferences
Business Wire - Wed Feb 26, 7:00AM CST
ACI Worldwide (NASDAQ: ACIW), a leading international provider of electronic payment and banking systems, announced today that company management will present at the following investor conferences:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading